-
1
-
-
78651276631
-
Diagnosis and classification of diabetes mellitus
-
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011; (Suppl 1)34:S62-S69.
-
(2011)
Diabetes Care
, vol.34
, pp. S62-S69
-
-
-
2
-
-
17044386953
-
Type 2 diabetes: Principles of pathogenesis and therapy
-
Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005;365:1333-1346.
-
(2005)
Lancet
, vol.365
, pp. 1333-1346
-
-
Stumvoll, M.1
Goldstein, B.J.2
Van Haeften, T.W.3
-
3
-
-
0036306096
-
American diabetes association GENNID study group: Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S
-
Jensen CC, Cnop M, Hull RL et al. American Diabetes Association GENNID Study Group: Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S. Diabetes 2002; 51:2170-2178.
-
(2002)
Diabetes
, vol.51
, pp. 2170-2178
-
-
Jensen, C.C.1
Cnop, M.2
Hull, R.L.3
-
4
-
-
33847636157
-
Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes
-
Cnop M, Vidal J, Hull RL et al. Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes. Diabetes Care 2007; 30:677-682.
-
(2007)
Diabetes Care
, vol.30
, pp. 677-682
-
-
Cnop, M.1
Vidal, J.2
Hull, R.L.3
-
5
-
-
0032742992
-
The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus
-
Weyer C, Bogardus C, Mott DM et al. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999; 104:787-794.
-
(1999)
J Clin Invest
, vol.104
, pp. 787-794
-
-
Weyer, C.1
Bogardus, C.2
Mott, D.M.3
-
6
-
-
33745302884
-
The natural course of beta-cell function in nondiabetic and diabetic individuals: The insulin resistance atherosclerosis study
-
Festa A, Williams K, D'Agostino R Jr. et al. The natural course of beta-cell function in nondiabetic and diabetic individuals: the insulin resistance atherosclerosis study. Diabetes 2006; 55:1114-1120.
-
(2006)
Diabetes
, vol.55
, pp. 1114-1120
-
-
Festa, A.1
Williams, K.2
D'Agostino, R.3
-
7
-
-
0031961242
-
Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: The 10-year follow-up of the Belfast diet study
-
Levy J, Atkinson AB, Bell PM et al. Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study. Diabet Med 1998; 15:290-296.
-
(1998)
Diabet Med
, vol.15
, pp. 290-296
-
-
Levy, J.1
Atkinson, A.B.2
Bell, P.M.3
-
8
-
-
0028817815
-
Overview of 6 years' therapy of type II diabetes: A progressive disease. UK prospective diabetes study group
-
UK Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. UK Prospective Diabetes Study Group. Diabetes 1995; 44:1249-1258.
-
(1995)
Diabetes
, vol.44
, pp. 1249-1258
-
-
-
9
-
-
0018149835
-
Islet morphometry in the diabetic pancreas of man
-
Saito K, Takahashi T, Yaginuma N et al. Islet morphometry in the diabetic pancreas of man. Tohoku J Exp Med 1978; 125:185-197.
-
(1978)
Tohoku J Exp Med
, vol.125
, pp. 185-197
-
-
Saito, K.1
Takahashi, T.2
Yaginuma, N.3
-
10
-
-
0018146301
-
The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus
-
Westermark P, Wilander E. The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia 1978; 15:417-421.
-
(1978)
Diabetologia
, vol.15
, pp. 417-421
-
-
Westermark, P.1
Wilander, E.2
-
11
-
-
0018641183
-
Differential volumetry of A, B and D-cells in the pancreatic islets of diabetic and non-diabetic subjects
-
Saito K, Yaginuma N, Takahashi T. Differential volumetry of A, B and D-cells in the pancreatic islets of diabetic and non-diabetic subjects. Tohoku J Exp Med 1979; 129:273-283.
-
(1979)
Tohoku J Exp Med
, vol.129
, pp. 273-283
-
-
Saito, K.1
Yaginuma, N.2
Takahashi, T.3
-
12
-
-
0019996086
-
Quantitation of endocrine cell content in the pancreas of nondiabetic and diabetic humans
-
Stefan Y, Orci L, Malaisse-Lagae F et al. Quantitation of endocrine cell content in the pancreas of nondiabetic and diabetic humans. Diabetes 1982; 31:694-700.
-
(1982)
Diabetes
, vol.31
, pp. 694-700
-
-
Stefan, Y.1
Orci, L.2
Malaisse-Lagae, F.3
-
13
-
-
0020623615
-
Cellular composition of the human diabetic pancreas
-
Rahier J, Goebbels RM, Henquin JC. Cellular composition of the human diabetic pancreas. Diabetologia 1983;24:366-371.
-
(1983)
Diabetologia
, vol.24
, pp. 366-371
-
-
Rahier, J.1
Goebbels, R.M.2
Henquin, J.C.3
-
14
-
-
0024213009
-
Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: Quantitative changes in the pancreas in type 2 diabetes
-
Clark A, Wells CA, Buley ID et al. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res 1988; 9:151-159.
-
(1988)
Diabetes Res
, vol.9
, pp. 151-159
-
-
Clark, A.1
Wells, C.A.2
Buley, I.D.3
-
15
-
-
0036163156
-
Reduced beta cell mass and expression of oxidative stress related DNA damage in the islets of Japanese type 2 diabetic patients
-
Sakuraba H, Mizukami H, Yagihashi N et al. Reduced beta cell mass and expression of oxidative stress related DNA damage in the islets of Japanese type 2 diabetic patients. Diabetologia 2002; 45:85-96.
-
(2002)
Diabetologia
, vol.45
, pp. 85-96
-
-
Sakuraba, H.1
Mizukami, H.2
Yagihashi, N.3
-
16
-
-
0038707331
-
Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes in Korea
-
Yoon KH, Ko SH, Cho JH et al. Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes in Korea. J Clin Endocrinol Metab 2003; 88:2300-2308.
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 2300-2308
-
-
Yoon, K.H.1
Ko, S.H.2
Cho, J.H.3
-
17
-
-
0037219411
-
Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes
-
Butler AE, Janson J, Bonner-Weir S et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52:102-110.
-
(2003)
Diabetes
, vol.52
, pp. 102-110
-
-
Butler, A.E.1
Janson, J.2
Bonner-Weir, S.3
-
18
-
-
43549100675
-
Islet amyloid in type 2 diabetes and the toxic oligomer hypothesis
-
Haataja L, Gurlo T, Huang CJ et al. Islet amyloid in type 2 diabetes and the toxic oligomer hypothesis. Endocr Rev 2008;29:303-316.
-
(2008)
Endocr Rev
, vol.29
, pp. 303-316
-
-
Haataja, L.1
Gurlo, T.2
Huang, C.J.3
-
19
-
-
53549093011
-
Pancreatic beta-cell mass in European subjects with type 2 diabetes
-
Rahier J, Guiot Y, Goebbels RM et al. Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 2008; 10(Suppl 4):32-42.
-
(2008)
Diabetes Obes Metab
, vol.10
, pp. 32-42
-
-
Rahier, J.1
Guiot, Y.2
Goebbels, R.M.3
-
20
-
-
77950290798
-
Beta-cell mass dynamics and islet cell plasticity in human type 2 diabetes
-
Hanley SC, Austin E, Assouline-Thomas B et al. Beta-cell mass dynamics and islet cell plasticity in human type 2 diabetes. Endocrinology 2010; 151:1462-1472.
-
(2010)
Endocrinology
, vol.151
, pp. 1462-1472
-
-
Hanley, S.C.1
Austin, E.2
Assouline-Thomas, B.3
-
21
-
-
35848963392
-
The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients
-
Marchetti P, Bugliani M, Lupi R et al. The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients. Diabetologia 2007; 50:2486-2494.
-
(2007)
Diabetologia
, vol.50
, pp. 2486-2494
-
-
Marchetti, P.1
Bugliani, M.2
Lupi, R.3
-
22
-
-
8744272467
-
Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin
-
Marchetti P, Del Guerra S, Marselli L et al. Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab 2004; 89:5535-5541.
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 5535-5541
-
-
Marchetti, P.1
Del Guerra, S.2
Marselli, L.3
-
23
-
-
33847677975
-
Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes
-
Laybutt DR, Preston AM, Åkerfeldt MC et al. Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia 2007; 50:752-763.
-
(2007)
Diabetologia
, vol.50
, pp. 752-763
-
-
Laybutt, D.R.1
Preston, A.M.2
Åkerfeldt, M.C.3
-
24
-
-
22544432640
-
Nomenclature committee on cell death: Classification of cell death: Recommendations of the nomenclature committee on cell death
-
Kroemer G, El-Deiry WS, Golstein P et al. Nomenclature committee on cell death: classification of cell death: recommendations of the nomenclature committee on cell death. Cell Death Differ 2005; 12(Suppl 2): 1463-1467.
-
(2005)
Cell Death Differ
, vol.12
, pp. 1463-1467
-
-
Kroemer, G.1
El-Deiry, W.S.2
Golstein, P.3
-
26
-
-
27644466759
-
Autophagy and signaling: Their role in cell survival and cell death
-
Codogno P, Meijer AJ. Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ 2005; 12(Suppl 2):1509-1518.
-
(2005)
Cell Death Differ
, vol.12
, pp. 1509-1518
-
-
Codogno, P.1
Meijer, A.J.2
-
27
-
-
67349150186
-
Autophagy in human type 2 diabetes pancreatic beta cells
-
Masini M, Bugliani M, Lupi R et al. Autophagy in human type 2 diabetes pancreatic beta cells. Diabetologia 2009;52:1083-1086.
-
(2009)
Diabetologia
, vol.52
, pp. 1083-1086
-
-
Masini, M.1
Bugliani, M.2
Lupi, R.3
-
28
-
-
2342457712
-
Beta cell differentiation during early human pancreas development
-
Piper K, Brickwood S, Turnpenny LW et al. Beta cell differentiation during early human pancreas development. J Endocrinol 2004; 181:11-23.
-
(2004)
J Endocrinol
, vol.181
, pp. 11-23
-
-
Piper, K.1
Brickwood, S.2
Turnpenny, L.W.3
-
29
-
-
77149127706
-
Beta-cell development and turnover during prenatal life in humans
-
Meier JJ, Kohler CU, Alkhatib B et al. Beta-cell development and turnover during prenatal life in humans. Eur J Endocrinol 2010; 152:559-568.
-
(2010)
Eur J Endocrinol
, vol.152
, pp. 559-568
-
-
Meier, J.J.1
Kohler, C.U.2
Alkhatib, B.3
-
30
-
-
0033853921
-
Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy
-
Kassem SA, Ariel I, Thornton PS et al. Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes 2000; 49:1325-1333.
-
(2000)
Diabetes
, vol.49
, pp. 1325-1333
-
-
Kassem, S.A.1
Ariel, I.2
Thornton, P.S.3
-
31
-
-
44749088201
-
Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans
-
Meier JJ, Butler AE, Saisho Y et al. Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes 2008; 57:1584-1594.
-
(2008)
Diabetes
, vol.57
, pp. 1584-1594
-
-
Meier, J.J.1
Butler, A.E.2
Saisho, Y.3
-
32
-
-
77949289481
-
The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation
-
Cnop M, Hughes SJ, Igoillo-Esteve M et al. The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation. Diabetologia 2010; 53:321-330.
-
(2010)
Diabetologia
, vol.53
, pp. 321-330
-
-
Cnop, M.1
Hughes, S.J.2
Igoillo-Esteve, M.3
-
33
-
-
77957787230
-
Significant human beta-cell turnover is limited to the first three decades of life as determined by in vivo thymidine analog incorporation and radiocarbon dating
-
Perl S, Kushner JA, Buchholz BA et al. Significant human beta-cell turnover is limited to the first three decades of life as determined by in vivo thymidine analog incorporation and radiocarbon dating. J Clin Endocrinol Metab 2010; 95:E234-E239.
-
(2010)
J Clin Endocrinol Metab
, vol.95
, pp. E234-E239
-
-
Perl, S.1
Kushner, J.A.2
Buchholz, B.A.3
-
34
-
-
77958040076
-
Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy
-
Butler AE, Cao-Minh L, Galasso R et al. Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia 2010; 53:2167-2176.
-
(2010)
Diabetologia
, vol.53
, pp. 2167-2176
-
-
Butler, A.E.1
Cao-Minh, L.2
Galasso, R.3
-
35
-
-
80052737348
-
Histopathology and ex vivo insulin secretion of pancreatic islets in gestational diabetes. A case report
-
in press
-
Tancredi M, Marselli L, Lencioni C et al. Histopathology and ex vivo insulin secretion of pancreatic islets in gestational diabetes. A case report. Islets 2011, in press.
-
(2011)
Islets
-
-
Tancredi, M.1
Marselli, L.2
Lencioni, C.3
-
36
-
-
58649120819
-
Reduced pancreatic volume and beta-cell area in patients with chronic pancreatitis
-
Schrader H, Menge BA, Schneider S et al. Reduced pancreatic volume and beta-cell area in patients with chronic pancreatitis. Gastroenterology 2009; 136:513-522.
-
(2009)
Gastroenterology
, vol.136
, pp. 513-522
-
-
Schrader, H.1
Menge, B.A.2
Schneider, S.3
-
37
-
-
58149477520
-
Metabolic consequences of a 50% partial pancreatectomy in humans
-
Menge BA, Schrader H, Breuer TG. Metabolic consequences of a 50% partial pancreatectomy in humans. Diabetologia 2009; 52:306-317.
-
(2009)
Diabetologia
, vol.52
, pp. 306-317
-
-
Menge, B.A.1
Schrader, H.2
Breuer, T.G.3
-
38
-
-
0026447606
-
Pancreatic exocrine and endocrine function after operations for chronic pancreatitis
-
Jalleh RP, Williamson RC. Pancreatic exocrine and endocrine function after operations for chronic pancreatitis. Ann Surg 1992; 216:656-662.
-
(1992)
Ann Surg
, vol.216
, pp. 656-662
-
-
Jalleh, R.P.1
Williamson, R.C.2
-
39
-
-
0025357136
-
Duodenum-preserving resection of the head of the pancreas in chronic pancreatitis with inflammatory mass in the head
-
Beger HG, Buchler M. Duodenum-preserving resection of the head of the pancreas in chronic pancreatitis with inflammatory mass in the head. World J Surg 1990; 14:83-87.
-
(1990)
World J Surg
, vol.14
, pp. 83-87
-
-
Beger, H.G.1
Buchler, M.2
-
40
-
-
79551705360
-
Segmental live donor pancreas transplantation: Review and critique of rationale, outcomes and current recommendations
-
Boggi U, Amorese G, Marchetti P et al. Segmental live donor pancreas transplantation: review and critique of rationale, outcomes and current recommendations. Clin Transplant 2011; 25:4-12.
-
(2011)
Clin Transplant
, vol.25
, pp. 4-12
-
-
Boggi, U.1
Amorese, G.2
Marchetti, P.3
-
41
-
-
0025342504
-
Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans
-
Kendall DM, Sutherland DE, Najarian JS et al. Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J Med 1990; 322:898-903.
-
(1990)
N Engl J Med
, vol.322
, pp. 898-903
-
-
Kendall, D.M.1
Sutherland, D.E.2
Najarian, J.S.3
-
42
-
-
49649125936
-
Risk of glucose intolerance and diabetes in hemipancreatectomized donors selected for normal preoperative glucose metabolism
-
Kumar AF, Gruessner RW, Seaquist ER. Risk of glucose intolerance and diabetes in hemipancreatectomized donors selected for normal preoperative glucose metabolism. Diabetes Care 2008; 31:1639-1643.
-
(2008)
Diabetes Care
, vol.31
, pp. 1639-1643
-
-
Kumar, A.F.1
Gruessner, R.W.2
Seaquist, E.R.3
-
43
-
-
0028057533
-
Enzymatic, metabolic and secretory patterns in human islets of type 2 (noninsulin-dependent) diabetic patients
-
Fernandez-Alvarez J, Conget I, Rasschaert J et al. Enzymatic, metabolic and secretory patterns in human islets of type 2 (noninsulin-dependent) diabetic patients. Diabetologia 1994; 37:177-181.
-
(1994)
Diabetologia
, vol.37
, pp. 177-181
-
-
Fernandez-Alvarez, J.1
Conget, I.2
Rasschaert, J.3
-
44
-
-
10744222060
-
Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects
-
Deng S, Vatamaniuk M, Huang X et al. Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes 2004; 53:624-632.
-
(2004)
Diabetes
, vol.53
, pp. 624-632
-
-
Deng, S.1
Vatamaniuk, M.2
Huang, X.3
-
45
-
-
20044390365
-
Functional and molecular defects of pancreatic islets in human type 2 diabetes
-
Del Guerra S, Lupi R, Marselli L et al. Functional and molecular defects of pancreatic islets in human type 2 diabetes. Diabetes 2005; 54:727-735.
-
(2005)
Diabetes
, vol.54
, pp. 727-735
-
-
Del Guerra, S.1
Lupi, R.2
Marselli, L.3
-
46
-
-
38149042694
-
An overview of pancreatic beta-cell defects in human type 2 diabetes: Implications for treatment
-
Marchetti P, Dotta F, Lauro D et al. An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment. Regul Pept 2008; 146:4-11.
-
(2008)
Regul Pept
, vol.146
, pp. 4-11
-
-
Marchetti, P.1
Dotta, F.2
Lauro, D.3
-
47
-
-
20244376316
-
Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients
-
Anello M, Lupi R, Spampinato D et al. Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients. Diabetologia 2005; 48:282-289.
-
(2005)
Diabetologia
, vol.48
, pp. 282-289
-
-
Anello, M.1
Lupi, R.2
Spampinato, D.3
-
48
-
-
23744439083
-
Loss of ARNT/HIFlbeta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes
-
Gunton JE, Kulkarni RN, Yim S et al. Loss of ARNT/HIFlbeta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 2005; 122:337-349.
-
(2005)
Cell
, vol.122
, pp. 337-349
-
-
Gunton, J.E.1
Kulkarni, R.N.2
Yim, S.3
-
49
-
-
33644772589
-
Impaired gene and protein expression of exocytotic soluble N-ethylmaleimide attachment protein receptor complex proteins in pancreatic islets of type 2 diabetic patients
-
Ostenson CG, Gaisano H, Sheu L et al. Impaired gene and protein expression of exocytotic soluble N-ethylmaleimide attachment protein receptor complex proteins in pancreatic islets of type 2 diabetic patients. Diabetes 2006; 55:435-440.
-
(2006)
Diabetes
, vol.55
, pp. 435-440
-
-
Ostenson, C.G.1
Gaisano, H.2
Sheu, L.3
-
50
-
-
38849135820
-
The diabetes-linked transcription factor Pax-4 is expressed in human pancreatic islets and is activated by mitogens and GLP-1
-
Brun T, Hu He KH, Lupi R et al. The diabetes-linked transcription factor Pax-4 is expressed in human pancreatic islets and is activated by mitogens and GLP-1. Hum Mol Genet 2008; 17:478-489.
-
(2008)
Hum Mol Genet
, vol.17
, pp. 478-489
-
-
Brun, T.1
Hu He, K.H.2
Lupi, R.3
-
51
-
-
34547702501
-
Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes
-
Lyssenko V, Lupi R, Marchetti P et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 2007; 117:2155-2163.
-
(2007)
J Clin Invest
, vol.117
, pp. 2155-2163
-
-
Lyssenko, V.1
Lupi, R.2
Marchetti, P.3
-
52
-
-
40849111440
-
Gene expression of purified beta cell tissue obtained from human pancreas with laser capture microdissection
-
Marselli L, Thorne J, Ahn YB et al. Gene expression of purified beta cell tissue obtained from human pancreas with laser capture microdissection. J Clin Endocrinol Metab 2008; 93:1045-1053.
-
(2008)
J Clin Endocrinol Metab
, vol.93
, pp. 1045-1053
-
-
Marselli, L.1
Thorne, J.2
Ahn, Y.B.3
-
53
-
-
77955364191
-
Gene expression profiles of Beta-cell enriched tissue obtained by laser capture microdissection from subjects with type 2 diabetes
-
Marselli L, Thorne J, Dahiya S et al. Gene expression profiles of Beta-cell enriched tissue obtained by laser capture microdissection from subjects with type 2 diabetes. PLoS One 2010; 5(7):ell499.
-
(2010)
PLoS One
, vol.5
, Issue.7
, pp. ell499
-
-
Marselli, L.1
Thorne, J.2
Dahiya, S.3
-
54
-
-
67249096093
-
Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function
-
Shu L, Matveyenko AV, Kerr-Conte J et al. Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function. Hum Mol Genet 2009; 18:2388-2299.
-
(2009)
Hum Mol Genet
, vol.18
, pp. 2388-2299
-
-
Shu, L.1
Matveyenko, A.V.2
Kerr-Conte, J.3
-
55
-
-
71549166982
-
Apoptotic, regenerative and immune-related signaling in human islets from type 2 diabetes individuals
-
Nyblom HK, Bugliani M, Fung E et al. Apoptotic, regenerative and immune-related signaling in human islets from type 2 diabetes individuals. J Proteome Res 2009; 8:5650-5656.
-
(2009)
J Proteome Res
, vol.8
, pp. 5650-5656
-
-
Nyblom, H.K.1
Bugliani, M.2
Fung, E.3
-
56
-
-
78649842241
-
Genomics, type 2 diabetes and obesity
-
McCarthy MI. Genomics, type 2 diabetes and obesity. N Engl J Med 2010; 363:2339-2350.
-
(2010)
N Engl J Med
, vol.363
, pp. 2339-2350
-
-
McCarthy, M.I.1
-
57
-
-
52649133436
-
Genes and type 2 diabetes mellitus
-
Groop L, Lyssenko V. Genes and type 2 diabetes mellitus. Curr Diab Rep 2008; 8:192-197.
-
(2008)
Curr Diab Rep
, vol.8
, pp. 192-197
-
-
Groop, L.1
Lyssenko, V.2
-
59
-
-
0036319044
-
Insulin secretory function is impaired in isolated human islets carrying the Gly(972)->Arg IRS-1 polymorphism
-
Marchetti P, Lupi R, Federici M et al. Insulin secretory function is impaired in isolated human islets carrying the Gly(972)->Arg IRS-1 polymorphism. Diabetes 2002; 51:1419-1424.
-
(2002)
Diabetes
, vol.51
, pp. 1419-1424
-
-
Marchetti, P.1
Lupi, R.2
Federici, M.3
-
60
-
-
0035220244
-
The common Arg972 polymorphism in insulin receptor substrate-1 causes apoptosis of human pancreatic islets
-
Federici M, Hribal ML, Ranalli M et al. The common Arg972 polymorphism in insulin receptor substrate-1 causes apoptosis of human pancreatic islets. FASEB J 2001; 15:22-24.
-
(2001)
FASEB J
, vol.15
, pp. 22-24
-
-
Federici, M.1
Hribal, M.L.2
Ranalli, M.3
-
61
-
-
79955872917
-
ENPP1 affects insulin action and secretion: Evidences from in vitro studies
-
Di Paola R, Caporarello N, Marucci A et al. ENPP1 affects insulin action and secretion: evidences from in vitro studies. PLoS One 2011; 6:el9462.
-
(2011)
PLoS One
, vol.6
, pp. el9462
-
-
Di Paola, R.1
Caporarello, N.2
Marucci, A.3
-
62
-
-
58149389465
-
The TRIB3 Q84R polymorphism and risk of early-onset type 2 diabetes
-
Prudente S, Scarpelli D, Chandalia M et al. The TRIB3 Q84R polymorphism and risk of early-onset type 2 diabetes. J Clin Endocrinol Metab 2009; 94:190-196.
-
(2009)
J Clin Endocrinol Metab
, vol.94
, pp. 190-196
-
-
Prudente, S.1
Scarpelli, D.2
Chandalia, M.3
-
63
-
-
61849101938
-
Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: A large human genome epidemiology (HuGE) review and meta-analysis
-
Tong Y, Lin Y, Zhang Y et al. Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis. BMC Med Genet 2009; 10:15.
-
(2009)
BMC Med Genet
, vol.10
, pp. 15
-
-
Tong, Y.1
Lin, Y.2
Zhang, Y.3
-
64
-
-
40949141938
-
Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets
-
Shu L, Sauter NS, Schulthess FT et al. Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets. Diabetes 2008; 57:645-653.
-
(2008)
Diabetes
, vol.57
, pp. 645-653
-
-
Shu, L.1
Sauter, N.S.2
Schulthess, F.T.3
-
65
-
-
58149175669
-
Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion
-
Lyssenko V, Nagorny CL, Erdos MR et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet 2009; 4:82-88.
-
(2009)
Nat Genet
, vol.4
, pp. 82-88
-
-
Lyssenko, V.1
Nagorny, C.L.2
Erdos, M.R.3
-
66
-
-
68949213757
-
Calpain-10 expression is elevated in pancreatic islets from patients with type 2 diabetes
-
Ling C, Groop L, Guerra SD et al. Calpain-10 expression is elevated in pancreatic islets from patients with type 2 diabetes. PLoS One 2009; 18;4(8):e6558.
-
(2009)
PLoS One
, vol.18
, Issue.4-8
, pp. e6558
-
-
Ling, C.1
Groop, L.2
Guerra, S.D.3
-
67
-
-
12444292715
-
A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects
-
Sesti G, Cardellini M, Marini MA et al. A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. Diabetes 2003; 52:1280-1283.
-
(2003)
Diabetes
, vol.52
, pp. 1280-1283
-
-
Sesti, G.1
Cardellini, M.2
Marini, M.A.3
-
68
-
-
33744965950
-
The E23K variant of KCNJ11 encoding the pancreatic beta-cell adenosine 5′-triphosphate-sensitive potassium channel subunit Kir6.2 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes
-
Sesti G, Laratta E, Cardellini M et al. The E23K variant of KCNJ11 encoding the pancreatic beta-cell adenosine 5′-triphosphate-sensitive potassium channel subunit Kir6.2 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes. J Clin Endocrinol Metab 2006; 91:2334-2339.
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 2334-2339
-
-
Sesti, G.1
Laratta, E.2
Cardellini, M.3
-
69
-
-
77950520084
-
Meta-analysis and functional effects of the SLC30A8 rs 13266634 polymorphism on isolated human pancreatic islets
-
Cauchi S, Del Guerra S, Choquet H et al. Meta-analysis and functional effects of the SLC30A8 rs 13266634 polymorphism on isolated human pancreatic islets. Mol Genet Metab 2010; 100:77-82.
-
(2010)
Mol Genet Metab
, vol.100
, pp. 77-82
-
-
Cauchi, S.1
Del Guerra, S.2
Choquet, H.3
-
70
-
-
0034982387
-
High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: A potential role for regulation of specific Bel family genes toward an apoptotic cell death program
-
Federici M, Hribal M, Perego L et al. High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bel family genes toward an apoptotic cell death program. Diabetes 2001; 50:1290-2301.
-
(2001)
Diabetes
, vol.50
, pp. 1290-2301
-
-
Federici, M.1
Hribal, M.2
Perego, L.3
-
71
-
-
6944246692
-
Increased O-glycosylation of insulin signaling proteins results in their impaired activation and enhanced susceptibility to apoptosis in pancreatic beta-cells
-
D'Alessandris C, Andreozzi F, Federici M et al. Increased O-glycosylation of insulin signaling proteins results in their impaired activation and enhanced susceptibility to apoptosis in pancreatic beta-cells. FASEB J 2004;18:959-961.
-
(2004)
FASEB J
, vol.18
, pp. 959-961
-
-
D'Alessandris, C.1
Andreozzi, F.2
Federici, M.3
-
72
-
-
33750502270
-
Oxidative stress and impaired insulin secretion in type 2 diabetes
-
Robertson RP. Oxidative stress and impaired insulin secretion in type 2 diabetes. Curr Opin Pharmacol 2006;6:615-619.
-
(2006)
Curr Opin Pharmacol
, vol.6
, pp. 615-619
-
-
Robertson, R.P.1
-
73
-
-
70349254097
-
Effects of exposure of human islet beta-cells to normal and high glucose levels with or without gliclazide or glibenclamide
-
Del Guerra S, D'Aleo V, Lupi R et al. Effects of exposure of human islet beta-cells to normal and high glucose levels with or without gliclazide or glibenclamide. Diabetes Metab 2009; 35:293-298.
-
(2009)
Diabetes Metab
, vol.35
, pp. 293-298
-
-
Del Guerra, S.1
D'Aleo, V.2
Lupi, R.3
-
74
-
-
0026033901
-
Abnormal sensitivity to glucose of human islets cultured in a high glucose medium: Partial reversibility after an additional culture in a normal glucose medium
-
Davalli AM, Ricordi C, Socci C et al. Abnormal sensitivity to glucose of human islets cultured in a high glucose medium: partial reversibility after an additional culture in a normal glucose medium. J Clin Endocrinol Metab 1991; 72:202-208.
-
(1991)
J Clin Endocrinol Metab
, vol.72
, pp. 202-208
-
-
Davalli, A.M.1
Ricordi, C.2
Socci, C.3
-
75
-
-
70350330155
-
Towards better understanding of the contributions of overwork and glucotoxicity to the beta cell inadequacy of type 2 diabetes
-
Weir GC, Marselli L, Marchetti P et al. Towards better understanding of the contributions of overwork and glucotoxicity to the beta cell inadequacy of type 2 diabetes. Diabetes Obes Metab 2009; 11(Suppl 4): 82-90.
-
(2009)
Diabetes Obes Metab
, vol.11
, pp. 82-90
-
-
Weir, G.C.1
Marselli, L.2
Marchetti, P.3
-
76
-
-
0032921702
-
The biguanide compound metformin prevents desensitization of human pancreatic islets induced by high glucose
-
Lupi R, Del Guerra S, Tellini C et al. The biguanide compound metformin prevents desensitization of human pancreatic islets induced by high glucose. Eur J Pharmacol 1999; 364:205-209.
-
(1999)
Eur J Pharmacol
, vol.364
, pp. 205-209
-
-
Lupi, R.1
Del Guerra, S.2
Tellini, C.3
-
77
-
-
5644248079
-
Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes
-
Robertson RP. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 2004; 279:42351-42354.
-
(2004)
J Biol Chem
, vol.279
, pp. 42351-42354
-
-
Robertson, R.P.1
-
78
-
-
45249089262
-
Oxidative stress: The vulnerable beta-cell
-
Lenzen S. Oxidative stress: the vulnerable beta-cell. Biochem Soc Trans 2008; 36:343-347.
-
(2008)
Biochem Soc Trans
, vol.36
, pp. 343-347
-
-
Lenzen, S.1
-
79
-
-
34447504557
-
Pancreatic islet beta-cell and oxidative stress: The importance of glutathione peroxidase
-
Robertson RP, Harmon JS. Pancreatic islet beta-cell and oxidative stress: the importance of glutathione peroxidase. FEBS Lett 2007; 581:3743-3748.
-
(2007)
FEBS Lett
, vol.581
, pp. 3743-3748
-
-
Robertson, R.P.1
Harmon, J.S.2
-
80
-
-
0019852821
-
CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse
-
Grankvist K, Marklund SL, Taljedal IB. CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. Biochem J 1981; 199: 393-398.
-
(1981)
Biochem J
, vol.199
, pp. 393-398
-
-
Grankvist, K.1
Marklund, S.L.2
Taljedal, I.B.3
-
81
-
-
0037341238
-
Glucose toxicity in beta-cells: Type 2 diabetes, good radicals gone bad and the glutathione connection
-
Robertson RP, Harmon J, Tran PO et al. Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad and the glutathione connection. Diabetes 2003; 52:581-587.
-
(2003)
Diabetes
, vol.52
, pp. 581-587
-
-
Robertson, R.P.1
Harmon, J.2
Tran, P.O.3
-
82
-
-
35848941295
-
Glutathione peroxidase protein expression and activity in human islets isolated for transplantation
-
Tonooka N, Oseid E, Zhou H et al. Glutathione peroxidase protein expression and activity in human islets isolated for transplantation. Clin Transplant 2007; 21:767-772.
-
(2007)
Clin Transplant
, vol.21
, pp. 767-772
-
-
Tonooka, N.1
Oseid, E.2
Zhou, H.3
-
83
-
-
0029401861
-
Differences in the expression of heat-shock proteins and antioxidant enzymes between human and rodent pancreatic islets: Implications for the pathogenesis of insulin-dependent diabetes mellitus
-
Welsh N, Margulis B, Borg LA et al. Differences in the expression of heat-shock proteins and antioxidant enzymes between human and rodent pancreatic islets: implications for the pathogenesis of insulin-dependent diabetes mellitus. Mol Med 1995; 1:806-820.
-
(1995)
Mol Med
, vol.1
, pp. 806-820
-
-
Welsh, N.1
Margulis, B.2
Borg, L.A.3
-
84
-
-
0141755328
-
A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes
-
Kashyap S, Belfort R, Gastaldelli A et al. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 2003; 52:2461-2474.
-
(2003)
Diabetes
, vol.52
, pp. 2461-2474
-
-
Kashyap, S.1
Belfort, R.2
Gastaldelli, A.3
-
85
-
-
79251585927
-
Lipid-induced pancreatic β-cell dysfunction: Focus on in vivo studies
-
Giacca A, Xiao C, Oprescu AI et al. Lipid-induced pancreatic β-cell dysfunction: focus on in vivo studies. Am J Physiol Endocrinol Metab 2011; 300:E255-E262.
-
(2011)
Am J Physiol Endocrinol Metab
, vol.300
, pp. E255-E262
-
-
Giacca, A.1
Xiao, C.2
Oprescu, A.I.3
-
86
-
-
0036315888
-
Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: Evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway and Bel-2 regulated
-
Lupi R, Dotta F, Marselli L et al. Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway and Bel-2 regulated. Diabetes 2002; 51:1437-1442.
-
(2002)
Diabetes
, vol.51
, pp. 1437-1442
-
-
Lupi, R.1
Dotta, F.2
Marselli, L.3
-
87
-
-
0345354674
-
Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function
-
Maedler K, Oberholzer J, Bucher P et al. Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes 2003; 52:726-733.
-
(2003)
Diabetes
, vol.52
, pp. 726-733
-
-
Maedler, K.1
Oberholzer, J.2
Bucher, P.3
-
88
-
-
0036924861
-
Different role of saturated and unsaturated fatty acids in beta-cell apoptosis
-
Eitel K, Staiger H, Brendel MD et al. Different role of saturated and unsaturated fatty acids in beta-cell apoptosis. Biochem Biophys Res Commun 2002; 299:853-856.
-
(2002)
Biochem Biophys Res Commun
, vol.299
, pp. 853-856
-
-
Eitel, K.1
Staiger, H.2
Brendel, M.D.3
-
89
-
-
0042922453
-
Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death
-
El-Assaad W, Buteau J, Peyot ML et al. Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. Endocrinology 2003; 144:4154-4163.
-
(2003)
Endocrinology
, vol.144
, pp. 4154-4163
-
-
El-Assaad, W.1
Buteau, J.2
Peyot, M.L.3
-
90
-
-
0029036835
-
Long-term exposure to fatty acids and ketones inhibits beta-cell function in human pancreatic islets of Langerhans
-
Zhou YP, Grill V. Long-term exposure to fatty acids and ketones inhibits beta-cell function in human pancreatic islets of Langerhans. J Clin Endocrinol Metab 1995; 80:1584-1590.
-
(1995)
J Clin Endocrinol Metab
, vol.80
, pp. 1584-1590
-
-
Zhou, Y.P.1
Grill, V.2
-
91
-
-
50549202600
-
The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus
-
Randle PJ, Garland PB, Hales CN et al. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; 13:785-789.
-
(1963)
Lancet
, vol.13
, pp. 785-789
-
-
Randle, P.J.1
Garland, P.B.2
Hales, C.N.3
-
92
-
-
11144354264
-
Non-esterified fatty acids are deleterious for human pancreatic islet function at physiological glucose concentration
-
Bouckenooghe T, Muharram G, D'Herbomez M et al. Non-esterified fatty acids are deleterious for human pancreatic islet function at physiological glucose concentration. Diabetologia 2004; 47:463-469.
-
(2004)
Diabetologia
, vol.47
, pp. 463-469
-
-
Bouckenooghe, T.1
Muharram, G.2
D'Herbomez, M.3
-
93
-
-
0036318319
-
Lipotoxicity in human pancreatic islets and the protective effect of metformin
-
Lupi R, Del Guerra S, Fierabracci V et al. Lipotoxicity in human pancreatic islets and the protective effect of metformin. Diabetes 2002; 51(Suppl 1):134-137.
-
(2002)
Diabetes
, vol.51
, pp. 134-137
-
-
Lupi, R.1
Del Guerra, S.2
Fierabracci, V.3
-
94
-
-
49649084031
-
Initiation and execution of lipotoxic ER stress in pancreatic beta-cells
-
Cunha DA, Hekerman P, Ladriere L et al. Initiation and execution of lipotoxic ER stress in pancreatic beta-cells. J Cell Sci 2008; 121:2308-2318.
-
(2008)
J Cell Sci
, vol.121
, pp. 2308-2318
-
-
Cunha, D.A.1
Hekerman, P.2
Ladriere, L.3
-
95
-
-
1642414416
-
Rosiglitazone prevents the impairment of human islet function induced by fatty acids: Evidence for a role of PPAR gamma2 in the modulation of insulin secretion
-
Lupi R, Del Guerra S, Marselli L et al. Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPAR gamma2 in the modulation of insulin secretion. Am J Physiol Endocrinol Metab 2004; 286:E560-E567.
-
(2004)
Am J Physiol Endocrinol Metab
, vol.286
, pp. E560-E567
-
-
Lupi, R.1
Del Guerra, S.2
Marselli, L.3
-
96
-
-
73249116246
-
Glucagon-like peptide-1 agonists protect pancreatic beta-cells from lipotoxic endoplasmic reticulum stress through up regulation of BiP and JunB
-
Cunha DA, Ladriere L, Ortis F et al. Glucagon-like peptide-1 agonists protect pancreatic beta-cells from lipotoxic endoplasmic reticulum stress through up regulation of BiP and JunB. Diabetes 2009; 58:2851-2862.
-
(2009)
Diabetes
, vol.58
, pp. 2851-2862
-
-
Cunha, D.A.1
Ladriere, L.2
Ortis, F.3
-
98
-
-
33847012626
-
Human islet amyloid polypeptide oligormers disrupt cell coupling, induce apoptosis and impair insulin secretion in isolated human islets
-
Ritzel RA, Meier JJ, Lin CY et al. Human islet amyloid polypeptide oligormers disrupt cell coupling, induce apoptosis and impair insulin secretion in isolated human islets. Diabetes 2007; 56:65-71.
-
(2007)
Diabetes
, vol.56
, pp. 65-71
-
-
Ritzel, R.A.1
Meier, J.J.2
Lin, C.Y.3
-
99
-
-
0023192941
-
Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuopeptide-like protein also present in normal islet cells
-
Westermark P, Wernstedt C, Wilander E et al. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuopeptide-like protein also present in normal islet cells. Proc Natl Acad Sci U S A 1987; 84:3881-3885.
-
(1987)
Proc Natl Acad Sci U S A
, vol.84
, pp. 3881-3885
-
-
Westermark, P.1
Wernstedt, C.2
Wilander, E.3
-
100
-
-
0023579739
-
Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients
-
Cooper GJ, Willis AC, Clark A et al. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A 1987; 84:8628-8632.
-
(1987)
Proc Natl Acad Sci U S A
, vol.84
, pp. 8628-8632
-
-
Cooper, G.J.1
Willis, A.C.2
Clark, A.3
-
101
-
-
0038015599
-
Replication increases beta cell vulnerability to human islet amyloid polypeptide-induced apoptosis
-
Ritzel RA, Butler PC. Replication increases beta cell vulnerability to human islet amyloid polypeptide-induced apoptosis. Diabetes 2003; 52:1701-1708.
-
(2003)
Diabetes
, vol.52
, pp. 1701-1708
-
-
Ritzel, R.A.1
Butler, P.C.2
-
102
-
-
33845467504
-
Inhibition of human IAPP fibril formation does not prevent beta cell death: Evidence for distinct actions of oligomers and fibrils of human IAPP
-
Meier JJ, Kayed R, Lin CY et al. Inhibition of human IAPP fibril formation does not prevent beta cell death: evidence for distinct actions of oligomers and fibrils of human IAPP. Am J Physiol Endocrinol Metab 2006; 291:E1317-E1324.
-
(2006)
Am J Physiol Endocrinol Metab
, vol.291
, pp. E1317-E1324
-
-
Meier, J.J.1
Kayed, R.2
Lin, C.Y.3
-
103
-
-
76149102617
-
Evidence for proteotoxicity in beta cells in type 2 diabetes: Toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway
-
Gurlo T, Ryazantsev S, Huang CJ et al. Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway. Am J Pathol 2010; 176:861-869.
-
(2010)
Am J Pathol
, vol.176
, pp. 861-869
-
-
Gurlo, T.1
Ryazantsev, S.2
Huang, C.J.3
-
104
-
-
28744444020
-
Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3′-kinase-dependent pathway
-
Lin CY, Gurlo T, Haataja L et al. Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3′-kinase-dependent pathway. J Clin Endocrinol Metab 2005; 90:6678-6686.
-
(2005)
J Clin Endocrinol Metab
, vol.90
, pp. 6678-6686
-
-
Lin, C.Y.1
Gurlo, T.2
Haataja, L.3
-
105
-
-
53749100698
-
Increased interleukin (IL)-1 beta messenger ribonucleic acid expression in beta-cells of individuals with type 2 diabetes and regulation of IL-1 beta in human islets by glucose and auto stimulation
-
Boni-Schnetzler M, Thorne J, Parnaud G et al. Increased interleukin (IL)-1 beta messenger ribonucleic acid expression in beta-cells of individuals with type 2 diabetes and regulation of IL-1 beta in human islets by glucose and auto stimulation. J Clin Endocrinol Metab 2008; 93:4065-4074.
-
(2008)
J Clin Endocrinol Metab
, vol.93
, pp. 4065-4074
-
-
Boni-Schnetzler, M.1
Thorne, J.2
Parnaud, G.3
-
107
-
-
67650685521
-
Islet-associated macrophages in type 2 diabetes
-
Richardson SJ, Willcox A, Bone AJ et al. Islet-associated macrophages in type 2 diabetes. Diabetologia 2009; 52:1686-1688.
-
(2009)
Diabetologia
, vol.52
, pp. 1686-1688
-
-
Richardson, S.J.1
Willcox, A.2
Bone, A.J.3
-
108
-
-
33644669584
-
Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or the type 2 diabetes milieu to human pancreatic islets?
-
Welsh N, Cnop M, Kharroubi I et al. Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or the type 2 diabetes milieu to human pancreatic islets? Diabetes 2005; 54: 3238-3244.
-
(2005)
Diabetes
, vol.54
, pp. 3238-3244
-
-
Welsh, N.1
Cnop, M.2
Kharroubi, I.3
-
109
-
-
77955658618
-
Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes
-
Igoillo-Esteve M, Marselli L, Cunha DA et al. Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes. Diabetologia 2010; 53:1395-1405.
-
(2010)
Diabetologia
, vol.53
, pp. 1395-1405
-
-
Igoillo-Esteve, M.1
Marselli, L.2
Cunha, D.A.3
-
110
-
-
34247170807
-
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
-
Larsen CM, Faulenbach M, Vaag A et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007; 356:1517-1526.
-
(2007)
N Engl J Med
, vol.356
, pp. 1517-1526
-
-
Larsen, C.M.1
Faulenbach, M.2
Vaag, A.3
-
111
-
-
75549088122
-
Goals of treatment for type 2 diabetes: Beta-cell preservation for glycemic control
-
Marchetti P, Lupi R, Del Guerra S et al. Goals of treatment for type 2 diabetes: beta-cell preservation for glycemic control. Diabetes Care 2009; 32 (Suppl 2):S178-S183.
-
(2009)
Diabetes Care
, vol.32
, pp. S178-S183
-
-
Marchetti, P.1
Lupi, R.2
Del Guerra, S.3
-
112
-
-
35649013806
-
Insulin secretion defects of human type 2 diabetic islets are corrected in vitro by a new reactive oxygen species scavenger
-
Lupi R, Del Guerra S, Mancarella R et al. Insulin secretion defects of human type 2 diabetic islets are corrected in vitro by a new reactive oxygen species scavenger. Diabetes Metab 2007; 33:340-345.
-
(2007)
Diabetes Metab
, vol.33
, pp. 340-345
-
-
Lupi, R.1
Del Guerra, S.2
Mancarella, R.3
-
113
-
-
33846006173
-
The incretin system: Glucagonlike peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
-
Drucker DJ, Nauck MA. The incretin system: glucagonlike peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 2006; 368:1696-1705.
-
(2006)
Lancet
, vol.368
, pp. 1696-1705
-
-
Drucker, D.J.1
Nauck, M.A.2
-
115
-
-
43149088031
-
Effects of exendin-4 on islets from type 2 diabetes patients
-
Lupi R, Mancarella R, Del Guerra S et al. Effects of exendin-4 on islets from type 2 diabetes patients. Diabetes Obes Metab 2008; 10:515-519.
-
(2008)
Diabetes Obes Metab
, vol.10
, pp. 515-519
-
-
Lupi, R.1
Mancarella, R.2
Del Guerra, S.3
|